Research and Markets: South and Central America Neurology Devices Market Outlook to 2018 – Interventional Neurology …

DUBLIN--(BUSINESS WIRE)--

Dublin - Research and Markets (http://www.researchandmarkets.com/research/hwzlxn/south_and_central) has announced the addition of GlobalData's new report "South and Central America Neurology Devices Market Outlook to 2018 - Interventional Neurology, Neurological Diagnostic Equipment, Neurostimulation Devices and Others" to their offering.

This report provides key market data on the South and Central America Neurology Devices market - Argentina, Brazil and Mexico. The report provides value (USD million) data for all the market categories - CSF Management, Interventional Neurology, Neurological Diagnostic Equipment, Neurostimulation Devices, Neurosurgical Products and Radiosurgery. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Scope:

- Countries covered include Argentina, Brazil and Mexico.

- Market size and company share data for Neurology Devices market categories - CSF Management, Interventional Neurology, Neurological Diagnostic Equipment, Neurostimulation Devices, Neurosurgical Products and Radiosurgery.

- Annualized market revenues (USD million) data for each of the market categories in each of the country. Data from 2004 to 2011, forecast forward for 7 years to 2018.

- 2011 company shares and distribution shares data for each of the market categories and countries.

- Global corporate-level profiles of key companies operating within the South and Central America Neurology Devices market..

Read more here:
Research and Markets: South and Central America Neurology Devices Market Outlook to 2018 - Interventional Neurology ...

Research and Markets: Greece Neurology Devices Investment Opportunities, Analysis and Forecasts to 2018

DUBLIN--(BUSINESS WIRE)--

Research and Markets (http://www.researchandmarkets.com/research/sbrccp/greece_neurology_d) has announced the addition of Global Markets Direct's new report "Greece Neurology Devices Investment Opportunities, Analysis and Forecasts to 2018" to their offering.

Greece Neurology Devices Investment Opportunities, Analysis and Forecasts to 2018, a new report by Global Markets Direct, provides key market data on the Greece Neurology Devices market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within six market categories - CSF Management, Interventional Neurology, Neurological Diagnostic Equipment, Neurostimulation Devices, Neurosurgical Products and Radiosurgery. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on key recent developments.

Scope

- Market size and company share data for Neurology Devices market categories - CSF Management, Interventional Neurology, Neurological Diagnostic Equipment, Neurostimulation Devices, Neurosurgical Products and Radiosurgery.

- Annualized market revenues (USD million), volume (units) and average price (USD) data for each of the segments and sub-segments within six market categories. Data from 2004 to 2011, forecast forward for 7 years to 2018.

- 2011 company shares and distribution shares data for each of the six market categories.

- Global corporate-level profiles of key companies operating within the Greece Neurology Devicesmarket.

- Key players covered include Medtronic, Inc., Stryker Corporation, St. Jude Medical, Inc., DePuy, Inc., Natus Medical Incorporated, Cadwell Laboratories, Inc. and others.

Reasons to buy

View original post here:
Research and Markets: Greece Neurology Devices Investment Opportunities, Analysis and Forecasts to 2018

Research and Markets: Middle East and Africa Neurology Devices Market Outlook to 2018 – Interventional Neurology …

DUBLIN--(BUSINESS WIRE)--

Dublin - Research and Markets (http://www.researchandmarkets.com/research/m42bj6/middle_east_and_af) has announced the addition of GlobalData's new report "Middle East and Africa Neurology Devices Market Outlook to 2018 - Interventional Neurology, Neurological Diagnostic Equipment, Neurostimulation Devices and Others" to their offering.

This new report provides key market data on the Middle East and Africa Neurology Devices market - Israel, Saudi Arabia and South Africa. The report provides value (USD million) data for all the market categories - CSF Management, Interventional Neurology, Neurological Diagnostic Equipment, Neurostimulation Devices and Neurosurgical Products. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Scope:

- Countries covered include Israel, Saudi Arabia and South Africa.

- Market size and company share data for Neurology Devices market categories - CSF Management, Interventional Neurology, Neurological Diagnostic Equipment, Neurostimulation Devices and Neurosurgical Products .

- Annualized market revenues (USD million) data for each of the market categories in each of the country. Data from 2004 to 2011, forecast forward for 7 years to 2018.

- 2011 company shares and distribution shares data for each of the market categories and countries.

- Global corporate-level profiles of key companies operating within the Middle East and Africa Neurology Devices market..

View post:
Research and Markets: Middle East and Africa Neurology Devices Market Outlook to 2018 - Interventional Neurology ...

Research and Markets: Asia-Pacific Neurology Devices Market Outlook to 2018 – Interventional Neurology, Neurological …

DUBLIN--(BUSINESS WIRE)--

Research and Markets (http://www.researchandmarkets.com/research/8srtgc/asiapacific_neuro) has announced the addition of GlobalData's new report "Asia-Pacific Neurology Devices Market Outlook to 2018 - Interventional Neurology, Neurological Diagnostic Equipment, Neurostimulation Devices and Others" to their offering.

GlobalData's new report, Asia-Pacific Neurology Devices Market Outlook to 2018 - Interventional Neurology, Neurological Diagnostic Equipment, Neurostimulation Devices and Others, provides key market data on the Asia-Pacific Neurology Devices market - Australia, China, India and Japan. The report provides value (USD million) data for all the market categories - CSF Management, Interventional Neurology, Neurological Diagnostic Equipment, Neurostimulation Devices, Neurosurgical Products and Radiosurgery. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants.

Scope

- Countries covered include Australia, China, India and Japan.

- Market size and company share data for Neurology Devices market categories - CSF Management, Interventional Neurology, Neurological Diagnostic Equipment, Neurostimulation Devices, Neurosurgical Products and Radiosurgery.

- Annualized market revenues (USD million) data for each of the market categories in each of the countries. Data from 2004 to 2011, forecast forward for 7 years to 2018.

- 2011 company shares and distribution shares data for each of the market categories and countries.

- Global corporate-level profiles of key companies operating within the Asia-Pacific Neurology Devices market.

Companies Mentioned

Read more from the original source:
Research and Markets: Asia-Pacific Neurology Devices Market Outlook to 2018 - Interventional Neurology, Neurological ...

Medical school entry test fails to widen access to profession

The Irish Times - Friday, June 1, 2012

SEN FLYNN, Education Editor

THE NEW entry and selection test for entry to medicine known as the Hpat has done little to widen access to the profession, according to a draft review for the Higher Education Authority.

The review also concludes that students who can afford to take expensive preparatory courses for the Hpat (Health Professions Admission Test) outperform others despite claims the exam presents a level playing field for all students. More than 50 per cent of Hpat candidates take commercial coaching courses, the review states.

The review by the medical schools and other experts concludes that students who repeat the Hpat perform significantly better.

In all, one-third of successful applicants in the past two years were actually repeat candidates, with many of them dropping out of other much-coveted college courses. More than 85 per cent of students who repeated the exam improved their scores.

The findings are unlikely to be welcomed by the Department of Education, which has promoted the Hpat as a new-style exam where compared to the Leaving Cert there is less reliance on rote learning.

But medical schools will be under pressure to make changes before the 2013 exam next February.

Education sources say possible changes include:

* Hpat scores will be valid for a period of one year only;

Read the rest here:
Medical school entry test fails to widen access to profession

University Hospitals Case Medical Center Experts Present at ASCO Annual Meeting

CLEVELAND, June 1, 2012 /PRNewswire/ --In a Phase 2 study presented at the 48th Annual Meeting of the American Society for Clinical Oncology (ASCO), clinical researchers from University Hospitals Case Medical Center's Seidman Cancer Center developed a more effective way to treat gynecologic cancers, shortening radiation treatment time from five weeks to three days.The new method, stereotactic body radiotherapy (SBRT), has been used on other types of cancer, but University Hospitals Case Medical Center is the first treatment facility to apply it to gynecologic cancers.

"Unlike traditional radiation therapy, SBRT uses focused radiation beams and targets well-defined tumors," says Charles Kunos, MD, study co-author and Director of Gynecologic Radiation Oncology at University Hospitals Case Medical Center and Associate Professor at Case Western Reserve University School of Medicine. "The highly specific nature of the procedure not only shortens treatment time, it limits the effect of the radiation on healthy tissues."

Dr. Kunos will present the study's findings during a general poster session on gynecologic cancer at ASCO on Sunday, June 3 from 8:00 a.m. 12:00 p.m.

Researchers from University Hospitals Case Medical Center's Seidman Cancer Center and Case Western Reserve University School of Medicine will present new research findings in 29 presentationsat ASCO, taking place June 1-5 in Chicago.

"The breadth and depth of this innovative cancer research presented at ASCO is truly outstanding," says Stan Gerson, MD, Director of the Seidman Cancer Center at UH Case Medical Center and the Case Comprehensive Cancer Center at Case Western Reserve University. "Our faculty members are making tremendous advances in hematology and oncology which is reflected in their being chosen for oral and poster presentations."

Other presentations of note include:

Sunday, June 3

General Poster Session: Gynecologic Cancer

Association of smoking with pulmonary recurrences among women with intermediate- to high-risk early-stage endometrial adenocarcinoma.

Abstract #5089: 8:00 a.m. 12:00 p.m.

See the article here:
University Hospitals Case Medical Center Experts Present at ASCO Annual Meeting

Calamarine® Omega-3 from Pharma Marine Chosen by Prominent Integrative Medical Doctor for Nutraceutical Line

FULLERTON, Calif.--(BUSINESS WIRE)--

Pharma Marine today announced that Dr. Leigh Erin Connealy, MD, a leading integrative physician based in Irvine, California, has joined other medical professionals by choosing sustainably sourced Calamarine omega-3 for her highly regarded Newport Natural Health nutraceutical products newportnaturalhealth.com. Calamarine omega-3 ingredients are made exclusively by Pharma Marine.

According to Dr. Connealy, We chose Calamarine for a variety of reasons, including the efficacious omega-3 ratio, the fact that Calamarine is produced in a uniquely ecologically friendly manner, and of course, purity and taste. Emphasizing the importance of DHA (Docosahexaenoic acid), Dr. Connealy continued, The Calamarine ingredient we have chosen delivers omega-3 in a ratio consistent with what people get when they eat a diet rich in seafood, which is at least twice as much DHA as EPA. My philosophy is to stick as close to nature as possible. We know that research shows DHA is the omega-3 fatty acid that our bodies really need and store at high levels.

Dr. Leigh Erin Connealy graduated from the University of Texas School of Public Health, and then the University of Health Sciences Chicago Medical School. She completed her post-graduate training at Harbor/UCLA Medical Center in Los Angeles, California. In 1992, Dr. Connealy founded the Center for New Medicine in Irvine, California, where she serves as Medical Director. Her practice is based in the belief that strictly treating health problems with medication does not find the root cause of illness.

About Pharma Marine Group

Pharma Marine is located on the west coast of Norway, near Aalesund, a region where refining fish oils dates back more than 150 years. In addition to advanced purification technologies that create exceptional taste and smell dynamics, the facility is a model for green manufacturing procedures that dramatically reduce environmental impact and carbon footprint. Pharma Marine Group is the only supplier of Calamari derived omega-3 concentrates. For more information, please visit our websitepharmamarine.com. For information specific to the Calamarine line of ingredients, please visit calamarine.com.

Read more from the original source:
Calamarine® Omega-3 from Pharma Marine Chosen by Prominent Integrative Medical Doctor for Nutraceutical Line

Human reproduction agency has little to show for $30-million

A federal agency that has been unable to deliver on its mandate to oversee assisted human reproduction and is now slated for closure spent nearly $50,000 to relocate its president to Vancouver as it was awaiting a Supreme Court ruling that would strip away much of its responsibilities.

When Elinor Wilson was appointed to head Assisted Human Reproduction Canada (AHRC) in 2007, she refused to move from Ottawa to the agency headquarters that had been established in British Columbia. So the small staff has operated out of two offices one in Ottawa and a lavish bureau on the West Coast that was never fully occupied and was traded last year for a smaller location.

But in October, 2011, as she was waiting for a Supreme Court ruling that divested her agency of many of its duties, Dr. Wilson had a change of heart and moved to Vancouver. That relocation cost $49,635, agency staff said Thursday.

Since that time, Dr. Wilson has spent more than $50,000 travelling back to Ottawa on behalf of the AHRC, whose activities are unclear given that it has never been provided with the regulations required to do its job. Repeated requests for interviews with Dr. Wilson this week were refused.

The agency, which was created by the former Liberal government and set up by the Harper Conservatives, was told in the March federal budget that its doors would be closed and any functions that are still being performed would be taken over by Health Canada.

There are still five staff members in the AHRCs Ottawa office and two in Vancouver. The operation is expected to wind down by the end of March, 2013.

The agency was supposed to enforce the Assisted Human Reproduction Act with the power to inspect fertility clinics, and issue, suspend and revoke their licences to operate. It was also expected to set rules for stem-cell research projects and make regulatory recommendations to the federal health minister.

But the Supreme Court in December, 2010, determined that provinces, and not the federal government, had the power to regulate and licence doctors and clinics offering fertility treatments a ruling that wiped out a large part of the agencys reason for existence. And Health Canada has written just one of the roughly 30 regulations that were required to put the Assisted Human Reproduction Act in effect.

According to the budget documents, the demise of the AHRC will save the government $9.5-million a year.

But Franoise Baylis, a bioethics professor at Dalhousie University who resigned as a member of the agencys board in 2010, said the government knows full well that thats not true because, even though the agency has been allotted $10-million in federal funding every year, it has never managed to spend that amount.

Read more:
Human reproduction agency has little to show for $30-million

Flies with restless legs syndrome point to a genetic cause

ScienceDaily (May 31, 2012) When flies are made to lose a gene with links to Restless Legs Syndrome (RLS), they suffer the same sleep disturbances and restlessness that human patients do. The findings reported online on May 31 in Current Biology, a Cell Press publication, strongly suggest a genetic basis for RLS, a condition in which patients complain of an irresistible urge to move that gets worse as they try to rest.

"Although widely prevalent, RLS is a disorder whose pathophysiological basis remains very poorly understood," said Subhabrata Sanyal of Emory University School of Medicine. "The major significance of our study is to highlight the fact that there might be a genetic basis for RLS. Understanding the function of these genes also helps to understand and diagnose the disease and may offer more focused therapeutic options that are currently limited to very general approaches."

Sanyal's team recognized that a number of genome-wide association studies in humans had suggested connections between RLS and variation in a single gene (BTBD9).

"BTBD9 function or its relationship to RLS and sleep were a complete mystery," Sanyal said.

His team realized that there might be a way to shed some light on that mystery in fruit flies. Flies have a single, highly conserved version of the human BTBD9. They decided to test whether the gene that had turned up in those human studies would have any effect on sleep in the insects. In fact, flies need sleep just like humans do, and their sleep patterns are influenced by the same kinds of brain chemistry.

The researchers now report that flies lacking their version of the RLS-associated gene do lose sleep as they move more. When those flies were treated with a drug used for RLS, they showed improvements in their sleep.

The studies also yielded evidence about how the RLS gene works by controlling dopamine levels in the brain as well as iron balance in cells. Sanyal said his team will continue to explore other RLS-related genes that have been identified in human studies in search of more details of their interaction and function.

"Our results support the idea that genetic regulation of dopamine and iron metabolism constitute the core pathophysiology of at least some forms of RLS," the researchers write.

More broadly, they say, the study emphasizes the utility of simple animals such as fruit flies in unraveling the genetics of sleep and sleep disorders.

Share this story on Facebook, Twitter, and Google:

Read the rest here:
Flies with restless legs syndrome point to a genetic cause

Inflammation, Aging and Cancer All Linked to One Gene

Category: Science & Technology Posted: June 1, 2012 04:59AM Author: Guest_Jim_*

A future with a failing body is not something anyone looks forward to, so researchers are looking for ways to control the process. We already have medications and treatments so senior citizens can stay active with each passing year, but researchers are still working towards a way to stop or completely reverse the aging process itself.

Studies have discovered that as people age, the telomeres at the ends of their chromosomes fall off. Preventing this from happening inhibits aging, but can also cause cancer, which is an unchecked and uncontrolled mutation of normal cells. Researchers have known that inflammation is also connected to aging and cancer, but did not know how these three, seemingly unconnected, things were intertwined. Those at NYU Langone Medical Center / New York University School of Medicine have discovered that the link is through the AUF1 gene.

This gene controls inflammation by turning off that natural response before septic shock can occur. What the researchers discovered is that AUF1 also triggers the activation of telomerase, an enzyme that repairs telomeres, or kills cells by not activating, to repair the telomeres. This one gene regulates inflammation, can prevent accelerated aging, and prevent cancer by not activating telomerase. The researchers' next step is to examine the human population to see if mutations of the AUF1 gene are linked to different diseases.

Visit link:
Inflammation, Aging and Cancer All Linked to One Gene

Shahid-Priyanka chemistry had to be developed

"This so-called chemistry has to be developed much before actors come in front of the camera," says Kunal who can be credited for some crackling chemistry he brought alive between his actors in films like HUM TUM and FANAA, "It is also the function of the script because in order to get those lovey-dovey encounters come alive on screen, you first need to get them right on paper."

CHECK OUT: Neha Sharma is Shahid's love interest in TERI MERI KAHAANI!

Kunal worked on that by writing the characters of Shahid and Priyanka in such a manner that they turned out to be extremely endearing.

"The thing is that today's ever demanding audience wants something different from its actors all the time. They want Shahid to do different things and push the envelope. This was the demand of TERI MERI KAHAANI as well as we are indeed doing something altogether different in the film. That made me zero in on Shahid," divulges Kunal, "As for Priyanka then well, she hasn't done too many love stories; especially a film like TERI MERI KAHAANI which is an out and out romantic entertainer. I felt that it was about time we bring her and Shahid together in a quintessential music love story like this."

Also starring Neha Sharma and Prachi Desai in principal roles, TERI MERI KAHAANI with music by Sajid-Wajid releases all over on 22nd June.

More:
Shahid-Priyanka chemistry had to be developed

Solon teen tries out for international chemistry team

SOLON For Stephen Tang, a junior at Solon High School, life is all about discovery.

I feel like we take a lot of things for granted, he said. Even plastic bags at the grocery store are a result of very complicated engineering and specialized processes.

In many ways, Tang sees the world as a big science experiment. Now he will have the opportunity to gather with some of the nations brightest students who share his interest in chemistry.

Tang earned the title of national chemistry champion and in doing so has qualified to compete for one of only four spots on the U.S. Chemistry Team. He originally competed against more than 12,000 high school students, taking a series of tests that led to the final 20 individuals.

Although he hopes to get a spot at the international competition, Tang said he has a bigger goal in mind of just having fun and meeting new people.

Im looking forward to meeting these other students who share my passion, he said. I just want to have fun and enjoy this opportunity.

The final four students will be selected as a result of their performance at a two-week intensive study camp at the U.S. Air Force Academy in Colorado. Students will compete at the camp June 5-20.

Every morning well get up, have breakfast, have four hours of chemistry lectures, have lunch and then have four hours of lab work, Tang explained.

The group will have a short break in the evening, and then after dinner they will have a daily assessment.

The camp ends with a comprehensive assessment, and that determines who will make it through, Tang said.

Read more from the original source:
Solon teen tries out for international chemistry team

Chemistry key for Fyfe, Foltz

LINCOLN Ryker Fyfe and Sam Foltz know each other pretty well.

The two former Grand Island Senior High athletes played football together for four years. Now, theyre heading as walk-ons to play for Nebraska this fall in Lincoln.

But before that, they have one more chance to hook up on a long pass or maybe a slant across the middle as teammates on the North team at the 2012 Shrine Bowl at 1:30 p.m. Saturday at Memorial Stadium in Lincoln.

Definitely the slant, Foltz said when asked about his favorite play Thursday at the Shrine Bowl Media Day at Nebraska Wesleyan University. Its hard to defend the slant.

Fyfe had a different favorite.

The deep ball is pretty nice, Fyfe said. I like that route. He can run fast. He can catch. Hes big and strong.

How about the slant?

The slant? Fyfe said. Our timing is good, so that works, too.

Just about everything worked for Fyfe and Foltz during their senior season last fall. The two were key players in the Islanders 9-2 season that ended in the second round of the state playoffs.

The 6-foot-5 Fyfe finished the year as one of the top passers in Class A, completing 120-of-204 passes for 1,921 yards and 20 touchdowns.

See more here:
Chemistry key for Fyfe, Foltz

Statistics show longevity of Sask. residents improving

No one can cheat death, but the longevity of Saskatchewan residents has improved.

According to life expectancy figures released Thursday by Statistics Canada, deaths in the province from 2008 to 2009 dropped to 8,972 from 9,243 - a decrease of 2.9 per cent.

Nationally, the drop in the death rate was less significant - to 238,418 from 238,617 - a change of 0.1 per cent.

In 2008, Saskatchewan had the second-highest standardized death rate of the provinces with 595 deaths per 100,000 people. A year later, that rate dropped to fourth with 574 deaths reported per 100,000 residents.

In keeping with past trends, statistics for 2007 to 2009 show Saskatchewan women were outliving men. The life expectancy at birth for men was 77 years and 82 for women.

As the population continues to grey, the provincial government is mapping out a plan to improve services and access for seniors.

"Seniors have told us that they want to remain at home independently as long as possible, so we're considering ways and doing some work over the next year of looking at how we can assist seniors to do that through some innovative models of care," said Linda Restau, director of continuing care and rehabilitation with the Ministry of Health.

In July, a new seniors personal care home benefit will come into effect to assist lowincome seniors who reside in private personal care homes.

Although most of the people living in long-term care homes are seniors, only five per cent of the province's older crowd reside in publicly funded long-term care facilities.

"We're really interested in looking at and considering, as our aging population grows, to meet their needs and maintain their dignity and assist them to remain at home independently for as long as possible," Restau said.

View post:
Statistics show longevity of Sask. residents improving

Lynn Tech classmates learn about industry from professionals

Home > News Lynn Tech classmates learn about industry from professionals By Thor Jourgensen / The Daily Item

LYNN James Niemann spent about 20 minutes explaining cellular biology to Lynn Vocational Technical Institute students Thursday at North Shore Community College.

Then he explained how he almost derailed the college education he needed to become a scientist.

"I blew a $54,000 scholarship," he said.

After losing focus on his studies at the University of Rhode Island, Niemann transferred to the University of New Hampshire, where he got his college career back on track.

"I didn't give up," he said.

Niemann, a Beverly resident who works for Danvers cell technology, and three other science professionals spent Thursday morning talking to 48 Lynn Tech, Salem High School and Wakefield-based Northeastern Metropolitan Regional Vocational School students about science careers and how to land them.

Niemann urged students to study subjects they love in college and apply for internships, stressing a semester spent washing laboratory glassware could lead to a job.

"You have to be hardworking and passionate about what you do," he said.

A long-time interest in science and high school biology teachers who encouraged him sent Neimann off to college enthusiastic, but unprepared. After he transferred to Manchester, Niemann earned an associates degree, then a bachelor's degree before pursuing advancing degrees.

More:
Lynn Tech classmates learn about industry from professionals

Roslyn Students Win Big At Science Competition

Friday, 01 June 2012 00:00

Roslyn High School seniors Benjamin Kornick and Kevin Sherwin both won Grand Awards at this years INTEL International Science and Engineering Fair held recently in Pittsburgh, PA.

More than 1,500 students from about 70 countries, states, and territories spent the week in Pittsburgh vying for hundreds of thousands of dollars in scholarships and prizes. Only the top 25 percent of competitors received Grand Awards.

Im so proud of both Ben and Kevin, said Dr. Allyson Weseley, Roslyns coordinator of secondary research, who accompanied the boys to Pittsburgh. Theyve both worked so hard, and its gratifying to see them receive this well-earned recognition.

Ben garnered the highest honor in the behavioral science category for his work on the relationship between various parenting behaviors and the risk behaviors teens exhibit on -and offline.

Ben conducted his research at Roslyn High School with the help of Dr. Weseley. In his study, OMG: Look Who Joined Facebook! The Relationship between Parenting and Adolescent Risk Behaviors, Ben found that parents who solicit information from their children about the childrens involvement in risk activities have children more likely to engage in such risky behaviors. Its possible that such questioning encourages teens to rebel, explained Ben. On the other hand, in terms of offline risk, Ben found that parental knowledge obtained via closeness and/or control was linked to teens involvement in fewer risk behaviors.

Ben received $3,000 for being amongst the first-place winners in behavioral science and another $5,000 for being named the Best in Category. In addition, Ben won two other awards at the fair. The American Psychological Association presented him with a third-place award and the National Institute on Drug Abuse gave him a second-place award and has invited him to Washington, DC to visit their offices and present his research this summer.

Kevin, who competed in the mathematical sciences category, earned a fourth-place award for his project Classifying Generic Smooth Curves in the Projective Plane Related to Algebraic Curves of Degree 5. Kevins work took a set of established mathematical rules called the Arnold Invariants and applied them to a novel set of curves. Interestingly, the Arnold Invariants were ineffective in distinguishing between degree 5 curves, a finding that Kevin says has ramifications in fields from quantum computing to circuitry. Kevin was mentored by Dr. Oleg Viro of Stony Brook University.

See the original post:
Roslyn Students Win Big At Science Competition